[Table/Fig-7]:

Distribution of all the patients as per their final/confirmed diagnostic category {reallocated into two broad groups as MALIGNANCY–NOT DIAGNOSED (consists of BENIGN, ATYPIA, SUSPICIOUS, etc if any) and MALIGNANCY–DIAGNOSED (consists of MALIGNANT category)} from HPE of excisional specimens in accordance with different CNB criteria { reallocated into two broad groups as MALIGNANCY–NOT DIAGNOSED (which includes category B2, B3, and B4) and MALIGNANCY DIAGNOSED (which includes category B5 only)} (n = 50).

		Diagnostic HPE		Total
		Malignancy - Diagnosed	Malignancy- Non- Diagnosed
CNB	Malignancy– Diagnose (B5)	35 (TP)	0 (FP)	35
	Malignancy- Not-Diagnosed (B2 + B3 + B4)	7 (FN)	8 (TN)	15
	Total	42	8	50